Medicare Enrolled

Dr. June-Chih Liu, M.D.

Neurology · Arcadia, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
660 W DUARTE RD STE A, Arcadia, CA 91007
6264469697
In practice since 2006 (20 years)
NPI: 1891768479 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Liu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Liu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Liu

Dr. June-Chih Liu is a neurology specialist in Arcadia, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Liu performed 1,718 Medicare services across 823 unique beneficiaries.

Between the years covered by Open Payments, Dr. Liu received a total of $40,540 from 62 pharmaceutical and/or device companies across 764 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Liu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 22% volume in CA $40,540 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,718
Medicare services
Top 22% in CA for neurology
823
Unique beneficiaries
$135
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
1,091 $144 $220
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
217 $95 $165
New patient office visit, complex (60-74 min) 156 $178 $400
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
57 $84 $200
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
48 $138 $245
Limited needle EMG of arm or leg muscles
A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area.
45 $54 $152
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
37 $45 $150
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
29 $206 $500
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
23 $148 $352
Functional task assessment
A test that evaluates a patient's ability to perform specific functional tasks relevant to their environment.
15 $85 $250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$40,540
Total received (2018-2024)
Avg $5,791/year across 7 years
Top 10% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
764
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,667 (58.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16,872 (41.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,853
2023
$9,428
2022
$12,612
2021
$2,906
2020
$3,839
2019
$2,344
2018
$3,557

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,301
Gilead Sciences, Inc.
$739
Teva Pharmaceuticals USA, Inc.
$544
Eisai Inc.
$441
Alexion Pharmaceuticals, Inc.
$422
GlaxoSmithKline, LLC.
$246
ABBVIE INC.
$216
Amgen Inc.
$205
Amneal Pharmaceuticals LLC
$199
Grifols USA, LLC
$190
PFIZER INC.
$183
ACADIA Pharmaceuticals Inc
$179
Novartis Pharmaceuticals Corporation
$160
Phathom Pharmaceuticals, Inc.
$150
Esperion Therapeutics, Inc.
$125
SK Life Science, Inc.
$96
AstraZeneca Pharmaceuticals LP
$80
Lundbeck LLC
$78
Kyowa Kirin, Inc.
$54
MDD US Operations, LLC
$42
UCB, Inc.
$40
Lilly USA, LLC
$40
ORPHALAN INC
$30
Merz Pharmaceuticals, LLC
$28
MITSUBISHI TANABE PHARMA AMERICA, INC.
$26
Neurelis, Inc.
$22
Otsuka America Pharmaceutical, Inc.
$19
Top 3 companies account for 44.1% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$16,506
Amgen Inc.
$1,843
Kyowa Kirin, Inc.
$1,335
Medtronic, Inc.
$1,316
Neurocrine Biosciences, Inc.
$1,309
UCB, Inc.
$1,049
Gilead Sciences, Inc.
$989
ACADIA Pharmaceuticals Inc
$937
Avanir Pharmaceuticals, Inc.
$846
SK Life Science, Inc.
$790
Sunovion Pharmaceuticals Inc.
$767
US WorldMeds, LLC
$742
ABBVIE INC.
$733
SANOFI-AVENTIS U.S. LLC
$687
Lundbeck LLC
$671
Lilly USA, LLC
$668
Alexion Pharmaceuticals, Inc.
$597
Amneal Pharmaceuticals LLC
$552
Alnylam Pharmaceuticals Inc.
$540
MDD US Operations, LLC
$539
Grifols USA, LLC
$448
Eisai Inc.
$441
Esperion Therapeutics, Inc.
$423
Otsuka America Pharmaceutical, Inc.
$405
AbbVie Inc.
$357
Abbott Laboratories
$343
Regeneron Healthcare Solutions, Inc.
$342
Corium, LLC
$328
PFIZER INC.
$309
Allergan, Inc.
$292
Amarin Pharma Inc.
$281
Novartis Pharmaceuticals Corporation
$274
Acorda Therapeutics, Inc
$274
GlaxoSmithKline, LLC.
$246
AstraZeneca Pharmaceuticals LP
$221
Biohaven Pharmaceutical Holding Company Ltd.
$205
Allergan Inc.
$171
Biohaven Pharmaceuticals, Inc.
$170
IMPEL PHARMACEUTICALS INC.
$166
Phathom Pharmaceuticals, Inc.
$150
Lexicon Pharmaceuticals, Inc.
$148
Horizon Therapeutics plc
$136
Biogen, Inc.
$133
Zyla Life Sciences, Inc.
$123
Adamas Pharmaceuticals, Inc.
$109
Vertical Pharmaceuticals, LLC
$101
Janssen Pharmaceuticals, Inc
$94
MITSUBISHI TANABE PHARMA AMERICA, INC.
$71
Ipsen Biopharmaceuticals, Inc
$62
Boston Scientific Corporation
$49
ARGENX US, INC.
$33
ORPHALAN INC
$30
Merz Pharmaceuticals, LLC
$28
Mallinckrodt Hospital Products Inc.
$24
ARBOR PHARMACEUTICALS, INC.
$22
Neurelis, Inc.
$22
Impax Laboratories, Inc.
$22
Ultragenyx Pharmaceutical Inc.
$20
CATALYST PHARMACEUTICALS, INC.
$19
Celgene Corporation
$18
Arbor Pharmaceuticals, Inc.
$16
Travere Therapeutics, Inc.
$1
Top 3 companies account for 48.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · APOKYN · APTIOM · AREXVY · AUSTEDO · Adlarity · Aimovig · Andexxa · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · COMIRNATY · CREXONT · CUVRIOR · Cholbam · DUOPA · Deep Brain Stimulation · Dysport · EMGALITY · EXSERVAN · FARXIGA · FIRDAPSE · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · Gocovri · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · Inpefa · KYNMOBI · LEQVIO · LINZESS · LYRICA · Leqembi · MYOBLOC · NAMZARIC · NEXLETOL · NEXLIZET · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · ONGENTYS · ONPATTRO · OSMOLEX ER · Ongentys · Otezla · PAXLOVID · PRALUENT · QULIPTA · RADICAVA · REXULTI · RYTARY · Repatha · Reveal LINQ · SOLIRIS · SPRIX · Soliris · TRULICITY · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIBERZI · VOQUEZNA · VRAYLAR · VYEPTI · VYVGART HYTRULO · Vascepa · Vemlidy · Vimpat · WAINUA · XADAGO · XARELTO · XCOPRI · Xadago · Xeomin · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (58%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for neurology in CA.

Looking for a neurology specialist in Arcadia?
Compare neurologists in the Arcadia area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
496
Per 100K population
5.0
County median income
$87,760
Nearest hospital
USC ARCADIA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Liu is a clinical cardiology specialist, with above-average Medicare volume (top 22% in CA), with low-engagement industry engagement in the top 10% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Liu experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Liu performed 1,091 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Liu receive payments from pharmaceutical companies?
Yes. Dr. Liu received a total of $40,540 from 62 companies across 764 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Liu's costs compare to other neurologists in Arcadia?
Dr. Liu's average Medicare payment per service is $135. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Liu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →